Grants for Advancing Preclinical Proof of Concept for Rare Diseases in New York (USA)
GrantID: 58001
Grant Funding Amount Low: $275,000
Deadline: June 2, 2025
Grant Amount High: $275,000
Summary
Grant to advance preclinical proof of concept studies, driving innovative solutions for rare diseases. Elevate scientific understanding and treatment strategies in this critical health field through cutting-edge research.
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Business & Commerce, Employment, Labor & Training Workforce, Environment, Health & Medical, Higher Education, Individual, Municipalities, Non-Profit Support Services, Research & Evaluation, Science, Technology Research & Development, Small Business in New York (USA).